Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
ACS Medicinal Chemistry Letters|August 23, 2021
Spirocyclic Thiohydantoin Antagonists of F877L and Wild-Type Androgen Receptor for Castration-Resistant Prostate CancerZhuming Zhang, Peter J Connolly, Luis Trabalón Escolar, et al.
Regulatory Toxicology and Pharmacology : RTP|March 17, 2023
Metabolism and disposition of JNJ-10450232 (NTM-006) in rats, dogs, monkeys and humansHeng-Keang Lim, Jie Chen, Wing Lam, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 27, 2014
Metabolism and excretion of canagliflozin in mice, rats, dogs, and humansRao N V S Mamidi, Filip Cuyckens, Jie Chen, et al.
Bioorganic & Medicinal Chemistry Letters|December 21, 2017
Discovery of novel benzo[b]thiophene tetrazoles as non-carboxylate GPR40 agonistsHui Huang, Michael P Winters, Sanath K Meegalla, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2005
Design, synthesis, and biological activity of potent and selective inhibitors of mast cell tryptaseCorey R Hopkins, Mark Czekaj, Steven S Kaye, et al.
Journal of Medicinal Chemistry|January 20, 2021
Discovery of JNJ-63576253: A Clinical Stage Androgen Receptor Antagonist for F877L Mutant and Wild-Type Castration-Resistant Prostate Cancer (mCRPC)Zhuming Zhang, Peter J Connolly, Heng Keang Lim, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 7, 2015
Contribution of metabolites to P450 inhibition-based drug-drug interactions: scholarship from the drug metabolism leadership group of the innovation and quality consortium metabolite groupHongbin Yu, Suresh K Balani, Weichao Chen, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Discovery of a GPR40 Superagonist: The Impact of Aryl Propionic Acid α-FluorinationHui Huang, Sanath K Meegalla, James C Lanter, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 11, 2009
The conduct of in vitro studies to address time-dependent inhibition of drug-metabolizing enzymes: a perspective of the pharmaceutical research and manufacturers of AmericaScott W Grimm, Heidi J Einolf, Steven D Hall, et al.
Journal of Medicinal Chemistry|January 14, 2012
Design and characterization of optimized adenosine A₂A/A₁ receptor antagonists for the treatment of Parkinson's diseaseBrian C Shook, Stefanie Rassnick, Nathaniel Wallace, et al.
Pageof 4